Immunopathology of cutaneous T-cell lymphomas.
K Nasu(University of Washington), Marshall E. Kadin(Roger Williams Medical Center), Eric C. Vonderheid(Johns Hopkins University), Jonathan W. Said(Cedars-Sinai Medical Center), Dianne Sako(University of Washington), John E. Olerud
PubMed
June 1, 1985
Cited by 125
Related Papers
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
|New England Journal of Medicine|1987|1.2k
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
|Journal of Clinical Oncology|2001|610
Defining early mycosis fungoides
|Journal of the American Academy of Dermatology|2005|543